StockNews.com lowered shares of Koninklijke Philips (NYSE:PHG – Free Report) from a buy rating to a hold rating in a research report released on Thursday.
Separately, Jefferies Financial Group raised shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold”.
Koninklijke Philips Trading Up 0.4 %
Institutional Trading of Koninklijke Philips
Hedge funds have recently modified their holdings of the stock. Allspring Global Investments Holdings LLC bought a new stake in shares of Koninklijke Philips in the 1st quarter worth $40,000. Envestnet Portfolio Solutions Inc. raised its stake in Koninklijke Philips by 9.8% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 23,475 shares of the technology company’s stock valued at $469,000 after purchasing an additional 2,102 shares in the last quarter. Sei Investments Co. raised its stake in Koninklijke Philips by 12.0% in the first quarter. Sei Investments Co. now owns 360,176 shares of the technology company’s stock valued at $7,204,000 after purchasing an additional 38,532 shares in the last quarter. Headlands Technologies LLC purchased a new stake in Koninklijke Philips in the first quarter valued at approximately $91,000. Finally, US Bancorp DE raised its stake in shares of Koninklijke Philips by 8.0% during the first quarter. US Bancorp DE now owns 74,673 shares of the technology company’s stock worth $1,493,000 after acquiring an additional 5,544 shares in the last quarter. Institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
See Also
- Five stocks we like better than Koninklijke Philips
- Basic Materials Stocks Investing
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- The 3 Best Fintech Stocks to Buy Now
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Time to Load Up on Home Builders?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.